Medifast (NYSE:MED) Issues Q3 2024 Earnings Guidance
Medifast (NYSE:MED – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Monday morning. The company provided EPS guidance of -0.700–0.050 for the period, compared to the consensus EPS estimate of -0.520. The company issued revenue guidance of $125.0 million-$145.0 million, compared to the consensus revenue estimate of $161.8 million. […]
More Stories
Primecap Management Co. CA Increases Position in Glaukos Co. (NYSE:GKOS)
Primecap Management Co. CA boosted its stake in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.0% during the...
Moors & Cabot Inc. Has $1.51 Million Stock Holdings in Kosmos Energy Ltd. (NYSE:KOS)
Moors & Cabot Inc. increased its stake in shares of Kosmos Energy Ltd. (NYSE:KOS – Free Report) by 3.5% during...
DexCom, Inc. (NASDAQ:DXCM) Holdings Lifted by Cornerstone Advisors LLC
Cornerstone Advisors LLC lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.0% in the 3rd...
Cypress Capital Group Sells 793 Shares of iShares Core MSCI EAFE ETF (BATS:IEFA)
Cypress Capital Group lessened its stake in shares of iShares Core MSCI EAFE ETF (BATS:IEFA – Free Report) by 7.5%...
Cypress Capital Group Has $437,000 Position in Entergy Corporation (NYSE:ETR)
Cypress Capital Group cut its stake in Entergy Corporation (NYSE:ETR – Free Report) by 4.4% in the 3rd quarter, Holdings...
Cypress Capital Group Buys Shares of 2,650 AstraZeneca PLC (NASDAQ:AZN)
Cypress Capital Group acquired a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, Holdings Channel...